Michelmann H W, Maier P, Ficsor G, Feldman D B
Mutat Res. 1978 Mar;57(1):77-84. doi: 10.1016/0027-5107(78)90236-1.
Rhesus monkeys (Macaca mulatta) were used to determine their effectiveness as experimental animals for different cytogenetic tests with mitomycin C (MC). The micronucleus test (MNT and/or chromosome analysis of blood and bone marrow were made before and/or after the treatment with mitomycin C. Thus, the controls data and treated data were obtained from the same animals. With the employed methology, the micronucleus test could not be performed on living animals. Less chromosomal damage was detected in the micronucleus test of post-mortem samples than in the chromosome analysis of bone marrow. No influence by the mutagen could be observed in lymphocyte chromosomes at any of the different times of analysis. In contrast to this, bone-marrow chromosomes seemed to be highly affected by mitomycin C at day 1, 2 and 3 after injection. However, before treatment and at day 14, 16 and 17 after treatment there was no visible increase in chromosomal aberration in bone marrow.
恒河猴(猕猴)被用于确定其作为丝裂霉素C(MC)不同细胞遗传学试验实验动物的有效性。在用丝裂霉素C治疗之前和/或之后进行微核试验(MNT)和/或血液及骨髓的染色体分析。因此,对照数据和处理后的数据来自同一批动物。采用所使用的方法,无法对活体动物进行微核试验。与骨髓染色体分析相比,死后样本微核试验中检测到的染色体损伤较少。在任何不同的分析时间,均未观察到诱变剂对淋巴细胞染色体的影响。与此相反,注射后第1、2和3天,骨髓染色体似乎受到丝裂霉素C的高度影响。然而,治疗前以及治疗后第14、16和17天,骨髓中染色体畸变未见明显增加。